Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300939): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Added qualifier: readability score (P590521): 0.000011549099478063191) |
||||||
Property / summary: None (English) / qualifier | |||||||
readability score: 0.000011549099478063191
|
Latest revision as of 11:01, 23 March 2024
Project Q3300939 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors |
Project Q3300939 in Germany |
Statements
374,380.01 Euro
0 references
467,975.01 Euro
0 references
80.0 percent
0 references
1 October 2020
0 references
30 September 2022
0 references
AmpliVak Immunotherapy GmbH
0 references
Hennigsdorf, Stadt
0 references
16 February 2024
0 references
Identifiers
DE_TEMPORARY_3741
0 references